Global Liposomes Drug Delivery Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Description

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.

In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.

According to our (Global Info Research) latest study, the global Liposomes Drug Delivery market size was valued at USD 3431.8 million in 2022 and is forecast to a readjusted size of USD 6506.7 million by 2029 with a CAGR of 9.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North America dominated the market with market share of 44% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12%.

Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma and Sigma-Tau Group are the top 6 players of Liposomes Drug Delivery, with about 77% market shares.

This report is a detailed and comprehensive analysis for global Liposomes Drug Delivery market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Liposomes Drug Delivery market size and forecasts, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (USD/Vial), 2018-2029
Global Liposomes Drug Delivery market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (USD/Vial), 2018-2029
Global Liposomes Drug Delivery market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (USD/Vial), 2018-2029
Global Liposomes Drug Delivery market shares of main players, shipments in revenue ($ Million), sales quantity (K Vials), and ASP (USD/Vial), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Liposomes Drug Delivery
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Liposomes Drug Delivery market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical and Luye Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Liposomes Drug Delivery market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Liposomal Doxorubicin
    Liposomal Amphoteracin B
    Liposomal Paclitaxel
    Others

Market segment by Application
    Fungal Infection Therapy
    Cancer & Tumor Therapy
    Others

Major players covered
    Johnson & Johnson
    Gilead Sciences
    Pacira
    Sun Pharmaceutical
    Luye Pharma
    Sigma-Tau Group
    Fudan-Zhangjiang
    Teva Pharmaceutical
    CSPC
    Novartis
    Kingond Pharm
    Spectrum Pharmaceuticals
    Shanghai New Asia

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Liposomes Drug Delivery product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Liposomes Drug Delivery, with price, sales, revenue and global market share of Liposomes Drug Delivery from 2018 to 2023.
Chapter 3, the Liposomes Drug Delivery competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Liposomes Drug Delivery breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Liposomes Drug Delivery market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Liposomes Drug Delivery.
Chapter 14 and 15, to describe Liposomes Drug Delivery sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Liposomes Drug Delivery
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Liposomes Drug Delivery Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Liposomal Doxorubicin
        1.3.3 Liposomal Amphoteracin B
        1.3.4 Liposomal Paclitaxel
        1.3.5 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Liposomes Drug Delivery Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Fungal Infection Therapy
        1.4.3 Cancer & Tumor Therapy
        1.4.4 Others
    1.5 Global Liposomes Drug Delivery Market Size & Forecast
        1.5.1 Global Liposomes Drug Delivery Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Liposomes Drug Delivery Sales Quantity (2018-2029)
        1.5.3 Global Liposomes Drug Delivery Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Johnson & Johnson
        2.1.1 Johnson & Johnson Details
        2.1.2 Johnson & Johnson Major Business
        2.1.3 Johnson & Johnson Liposomes Drug Delivery Product and Services
        2.1.4 Johnson & Johnson Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Johnson & Johnson Recent Developments/Updates
    2.2 Gilead Sciences
        2.2.1 Gilead Sciences Details
        2.2.2 Gilead Sciences Major Business
        2.2.3 Gilead Sciences Liposomes Drug Delivery Product and Services
        2.2.4 Gilead Sciences Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Gilead Sciences Recent Developments/Updates
    2.3 Pacira
        2.3.1 Pacira Details
        2.3.2 Pacira Major Business
        2.3.3 Pacira Liposomes Drug Delivery Product and Services
        2.3.4 Pacira Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Pacira Recent Developments/Updates
    2.4 Sun Pharmaceutical
        2.4.1 Sun Pharmaceutical Details
        2.4.2 Sun Pharmaceutical Major Business
        2.4.3 Sun Pharmaceutical Liposomes Drug Delivery Product and Services
        2.4.4 Sun Pharmaceutical Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Sun Pharmaceutical Recent Developments/Updates
    2.5 Luye Pharma
        2.5.1 Luye Pharma Details
        2.5.2 Luye Pharma Major Business
        2.5.3 Luye Pharma Liposomes Drug Delivery Product and Services
        2.5.4 Luye Pharma Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Luye Pharma Recent Developments/Updates
    2.6 Sigma-Tau Group
        2.6.1 Sigma-Tau Group Details
        2.6.2 Sigma-Tau Group Major Business
        2.6.3 Sigma-Tau Group Liposomes Drug Delivery Product and Services
        2.6.4 Sigma-Tau Group Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Sigma-Tau Group Recent Developments/Updates
    2.7 Fudan-Zhangjiang
        2.7.1 Fudan-Zhangjiang Details
        2.7.2 Fudan-Zhangjiang Major Business
        2.7.3 Fudan-Zhangjiang Liposomes Drug Delivery Product and Services
        2.7.4 Fudan-Zhangjiang Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Fudan-Zhangjiang Recent Developments/Updates
    2.8 Teva Pharmaceutical
        2.8.1 Teva Pharmaceutical Details
        2.8.2 Teva Pharmaceutical Major Business
        2.8.3 Teva Pharmaceutical Liposomes Drug Delivery Product and Services
        2.8.4 Teva Pharmaceutical Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Teva Pharmaceutical Recent Developments/Updates
    2.9 CSPC
        2.9.1 CSPC Details
        2.9.2 CSPC Major Business
        2.9.3 CSPC Liposomes Drug Delivery Product and Services
        2.9.4 CSPC Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 CSPC Recent Developments/Updates
    2.10 Novartis
        2.10.1 Novartis Details
        2.10.2 Novartis Major Business
        2.10.3 Novartis Liposomes Drug Delivery Product and Services
        2.10.4 Novartis Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Novartis Recent Developments/Updates
    2.11 Kingond Pharm
        2.11.1 Kingond Pharm Details
        2.11.2 Kingond Pharm Major Business
        2.11.3 Kingond Pharm Liposomes Drug Delivery Product and Services
        2.11.4 Kingond Pharm Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Kingond Pharm Recent Developments/Updates
    2.12 Spectrum Pharmaceuticals
        2.12.1 Spectrum Pharmaceuticals Details
        2.12.2 Spectrum Pharmaceuticals Major Business
        2.12.3 Spectrum Pharmaceuticals Liposomes Drug Delivery Product and Services
        2.12.4 Spectrum Pharmaceuticals Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Spectrum Pharmaceuticals Recent Developments/Updates
    2.13 Shanghai New Asia
        2.13.1 Shanghai New Asia Details
        2.13.2 Shanghai New Asia Major Business
        2.13.3 Shanghai New Asia Liposomes Drug Delivery Product and Services
        2.13.4 Shanghai New Asia Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Shanghai New Asia Recent Developments/Updates

3 Competitive Environment: Liposomes Drug Delivery by Manufacturer
    3.1 Global Liposomes Drug Delivery Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Liposomes Drug Delivery Revenue by Manufacturer (2018-2023)
    3.3 Global Liposomes Drug Delivery Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Liposomes Drug Delivery by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Liposomes Drug Delivery Manufacturer Market Share in 2022
        3.4.2 Top 6 Liposomes Drug Delivery Manufacturer Market Share in 2022
    3.5 Liposomes Drug Delivery Market: Overall Company Footprint Analysis
        3.5.1 Liposomes Drug Delivery Market: Region Footprint
        3.5.2 Liposomes Drug Delivery Market: Company Product Type Footprint
        3.5.3 Liposomes Drug Delivery Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Liposomes Drug Delivery Market Size by Region
        4.1.1 Global Liposomes Drug Delivery Sales Quantity by Region (2018-2029)
        4.1.2 Global Liposomes Drug Delivery Consumption Value by Region (2018-2029)
        4.1.3 Global Liposomes Drug Delivery Average Price by Region (2018-2029)
    4.2 North America Liposomes Drug Delivery Consumption Value (2018-2029)
    4.3 Europe Liposomes Drug Delivery Consumption Value (2018-2029)
    4.4 Asia-Pacific Liposomes Drug Delivery Consumption Value (2018-2029)
    4.5 South America Liposomes Drug Delivery Consumption Value (2018-2029)
    4.6 Middle East and Africa Liposomes Drug Delivery Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Liposomes Drug Delivery Sales Quantity by Type (2018-2029)
    5.2 Global Liposomes Drug Delivery Consumption Value by Type (2018-2029)
    5.3 Global Liposomes Drug Delivery Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Liposomes Drug Delivery Sales Quantity by Application (2018-2029)
    6.2 Global Liposomes Drug Delivery Consumption Value by Application (2018-2029)
    6.3 Global Liposomes Drug Delivery Average Price by Application (2018-2029)

7 North America
    7.1 North America Liposomes Drug Delivery Sales Quantity by Type (2018-2029)
    7.2 North America Liposomes Drug Delivery Sales Quantity by Application (2018-2029)
    7.3 North America Liposomes Drug Delivery Market Size by Country
        7.3.1 North America Liposomes Drug Delivery Sales Quantity by Country (2018-2029)
        7.3.2 North America Liposomes Drug Delivery Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Liposomes Drug Delivery Sales Quantity by Type (2018-2029)
    8.2 Europe Liposomes Drug Delivery Sales Quantity by Application (2018-2029)
    8.3 Europe Liposomes Drug Delivery Market Size by Country
        8.3.1 Europe Liposomes Drug Delivery Sales Quantity by Country (2018-2029)
        8.3.2 Europe Liposomes Drug Delivery Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Liposomes Drug Delivery Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Liposomes Drug Delivery Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Liposomes Drug Delivery Market Size by Region
        9.3.1 Asia-Pacific Liposomes Drug Delivery Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Liposomes Drug Delivery Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Liposomes Drug Delivery Sales Quantity by Type (2018-2029)
    10.2 South America Liposomes Drug Delivery Sales Quantity by Application (2018-2029)
    10.3 South America Liposomes Drug Delivery Market Size by Country
        10.3.1 South America Liposomes Drug Delivery Sales Quantity by Country (2018-2029)
        10.3.2 South America Liposomes Drug Delivery Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Liposomes Drug Delivery Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Liposomes Drug Delivery Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Liposomes Drug Delivery Market Size by Country
        11.3.1 Middle East & Africa Liposomes Drug Delivery Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Liposomes Drug Delivery Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Liposomes Drug Delivery Market Drivers
    12.2 Liposomes Drug Delivery Market Restraints
    12.3 Liposomes Drug Delivery Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Liposomes Drug Delivery and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Liposomes Drug Delivery
    13.3 Liposomes Drug Delivery Production Process
    13.4 Liposomes Drug Delivery Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Liposomes Drug Delivery Typical Distributors
    14.3 Liposomes Drug Delivery Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Liposomes Drug Delivery Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Liposomes Drug Delivery Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 4. Johnson & Johnson Major Business
    Table 5. Johnson & Johnson Liposomes Drug Delivery Product and Services
    Table 6. Johnson & Johnson Liposomes Drug Delivery Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Johnson & Johnson Recent Developments/Updates
    Table 8. Gilead Sciences Basic Information, Manufacturing Base and Competitors
    Table 9. Gilead Sciences Major Business
    Table 10. Gilead Sciences Liposomes Drug Delivery Product and Services
    Table 11. Gilead Sciences Liposomes Drug Delivery Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Gilead Sciences Recent Developments/Updates
    Table 13. Pacira Basic Information, Manufacturing Base and Competitors
    Table 14. Pacira Major Business
    Table 15. Pacira Liposomes Drug Delivery Product and Services
    Table 16. Pacira Liposomes Drug Delivery Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Pacira Recent Developments/Updates
    Table 18. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 19. Sun Pharmaceutical Major Business
    Table 20. Sun Pharmaceutical Liposomes Drug Delivery Product and Services
    Table 21. Sun Pharmaceutical Liposomes Drug Delivery Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Sun Pharmaceutical Recent Developments/Updates
    Table 23. Luye Pharma Basic Information, Manufacturing Base and Competitors
    Table 24. Luye Pharma Major Business
    Table 25. Luye Pharma Liposomes Drug Delivery Product and Services
    Table 26. Luye Pharma Liposomes Drug Delivery Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Luye Pharma Recent Developments/Updates
    Table 28. Sigma-Tau Group Basic Information, Manufacturing Base and Competitors
    Table 29. Sigma-Tau Group Major Business
    Table 30. Sigma-Tau Group Liposomes Drug Delivery Product and Services
    Table 31. Sigma-Tau Group Liposomes Drug Delivery Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Sigma-Tau Group Recent Developments/Updates
    Table 33. Fudan-Zhangjiang Basic Information, Manufacturing Base and Competitors
    Table 34. Fudan-Zhangjiang Major Business
    Table 35. Fudan-Zhangjiang Liposomes Drug Delivery Product and Services
    Table 36. Fudan-Zhangjiang Liposomes Drug Delivery Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Fudan-Zhangjiang Recent Developments/Updates
    Table 38. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 39. Teva Pharmaceutical Major Business
    Table 40. Teva Pharmaceutical Liposomes Drug Delivery Product and Services
    Table 41. Teva Pharmaceutical Liposomes Drug Delivery Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Teva Pharmaceutical Recent Developments/Updates
    Table 43. CSPC Basic Information, Manufacturing Base and Competitors
    Table 44. CSPC Major Business
    Table 45. CSPC Liposomes Drug Delivery Product and Services
    Table 46. CSPC Liposomes Drug Delivery Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. CSPC Recent Developments/Updates
    Table 48. Novartis Basic Information, Manufacturing Base and Competitors
    Table 49. Novartis Major Business
    Table 50. Novartis Liposomes Drug Delivery Product and Services
    Table 51. Novartis Liposomes Drug Delivery Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Novartis Recent Developments/Updates
    Table 53. Kingond Pharm Basic Information, Manufacturing Base and Competitors
    Table 54. Kingond Pharm Major Business
    Table 55. Kingond Pharm Liposomes Drug Delivery Product and Services
    Table 56. Kingond Pharm Liposomes Drug Delivery Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Kingond Pharm Recent Developments/Updates
    Table 58. Spectrum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 59. Spectrum Pharmaceuticals Major Business
    Table 60. Spectrum Pharmaceuticals Liposomes Drug Delivery Product and Services
    Table 61. Spectrum Pharmaceuticals Liposomes Drug Delivery Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Spectrum Pharmaceuticals Recent Developments/Updates
    Table 63. Shanghai New Asia Basic Information, Manufacturing Base and Competitors
    Table 64. Shanghai New Asia Major Business
    Table 65. Shanghai New Asia Liposomes Drug Delivery Product and Services
    Table 66. Shanghai New Asia Liposomes Drug Delivery Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. Shanghai New Asia Recent Developments/Updates
    Table 68. Global Liposomes Drug Delivery Sales Quantity by Manufacturer (2018-2023) & (K Vials)
    Table 69. Global Liposomes Drug Delivery Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 70. Global Liposomes Drug Delivery Average Price by Manufacturer (2018-2023) & (USD/Vial)
    Table 71. Market Position of Manufacturers in Liposomes Drug Delivery, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 72. Head Office and Liposomes Drug Delivery Production Site of Key Manufacturer
    Table 73. Liposomes Drug Delivery Market: Company Product Type Footprint
    Table 74. Liposomes Drug Delivery Market: Company Product Application Footprint
    Table 75. Liposomes Drug Delivery New Market Entrants and Barriers to Market Entry
    Table 76. Liposomes Drug Delivery Mergers, Acquisition, Agreements, and Collaborations
    Table 77. Global Liposomes Drug Delivery Sales Quantity by Region (2018-2023) & (K Vials)
    Table 78. Global Liposomes Drug Delivery Sales Quantity by Region (2024-2029) & (K Vials)
    Table 79. Global Liposomes Drug Delivery Consumption Value by Region (2018-2023) & (USD Million)
    Table 80. Global Liposomes Drug Delivery Consumption Value by Region (2024-2029) & (USD Million)
    Table 81. Global Liposomes Drug Delivery Average Price by Region (2018-2023) & (USD/Vial)
    Table 82. Global Liposomes Drug Delivery Average Price by Region (2024-2029) & (USD/Vial)
    Table 83. Global Liposomes Drug Delivery Sales Quantity by Type (2018-2023) & (K Vials)
    Table 84. Global Liposomes Drug Delivery Sales Quantity by Type (2024-2029) & (K Vials)
    Table 85. Global Liposomes Drug Delivery Consumption Value by Type (2018-2023) & (USD Million)
    Table 86. Global Liposomes Drug Delivery Consumption Value by Type (2024-2029) & (USD Million)
    Table 87. Global Liposomes Drug Delivery Average Price by Type (2018-2023) & (USD/Vial)
    Table 88. Global Liposomes Drug Delivery Average Price by Type (2024-2029) & (USD/Vial)
    Table 89. Global Liposomes Drug Delivery Sales Quantity by Application (2018-2023) & (K Vials)
    Table 90. Global Liposomes Drug Delivery Sales Quantity by Application (2024-2029) & (K Vials)
    Table 91. Global Liposomes Drug Delivery Consumption Value by Application (2018-2023) & (USD Million)
    Table 92. Global Liposomes Drug Delivery Consumption Value by Application (2024-2029) & (USD Million)
    Table 93. Global Liposomes Drug Delivery Average Price by Application (2018-2023) & (USD/Vial)
    Table 94. Global Liposomes Drug Delivery Average Price by Application (2024-2029) & (USD/Vial)
    Table 95. North America Liposomes Drug Delivery Sales Quantity by Type (2018-2023) & (K Vials)
    Table 96. North America Liposomes Drug Delivery Sales Quantity by Type (2024-2029) & (K Vials)
    Table 97. North America Liposomes Drug Delivery Sales Quantity by Application (2018-2023) & (K Vials)
    Table 98. North America Liposomes Drug Delivery Sales Quantity by Application (2024-2029) & (K Vials)
    Table 99. North America Liposomes Drug Delivery Sales Quantity by Country (2018-2023) & (K Vials)
    Table 100. North America Liposomes Drug Delivery Sales Quantity by Country (2024-2029) & (K Vials)
    Table 101. North America Liposomes Drug Delivery Consumption Value by Country (2018-2023) & (USD Million)
    Table 102. North America Liposomes Drug Delivery Consumption Value by Country (2024-2029) & (USD Million)
    Table 103. Europe Liposomes Drug Delivery Sales Quantity by Type (2018-2023) & (K Vials)
    Table 104. Europe Liposomes Drug Delivery Sales Quantity by Type (2024-2029) & (K Vials)
    Table 105. Europe Liposomes Drug Delivery Sales Quantity by Application (2018-2023) & (K Vials)
    Table 106. Europe Liposomes Drug Delivery Sales Quantity by Application (2024-2029) & (K Vials)
    Table 107. Europe Liposomes Drug Delivery Sales Quantity by Country (2018-2023) & (K Vials)
    Table 108. Europe Liposomes Drug Delivery Sales Quantity by Country (2024-2029) & (K Vials)
    Table 109. Europe Liposomes Drug Delivery Consumption Value by Country (2018-2023) & (USD Million)
    Table 110. Europe Liposomes Drug Delivery Consumption Value by Country (2024-2029) & (USD Million)
    Table 111. Asia-Pacific Liposomes Drug Delivery Sales Quantity by Type (2018-2023) & (K Vials)
    Table 112. Asia-Pacific Liposomes Drug Delivery Sales Quantity by Type (2024-2029) & (K Vials)
    Table 113. Asia-Pacific Liposomes Drug Delivery Sales Quantity by Application (2018-2023) & (K Vials)
    Table 114. Asia-Pacific Liposomes Drug Delivery Sales Quantity by Application (2024-2029) & (K Vials)
    Table 115. Asia-Pacific Liposomes Drug Delivery Sales Quantity by Region (2018-2023) & (K Vials)
    Table 116. Asia-Pacific Liposomes Drug Delivery Sales Quantity by Region (2024-2029) & (K Vials)
    Table 117. Asia-Pacific Liposomes Drug Delivery Consumption Value by Region (2018-2023) & (USD Million)
    Table 118. Asia-Pacific Liposomes Drug Delivery Consumption Value by Region (2024-2029) & (USD Million)
    Table 119. South America Liposomes Drug Delivery Sales Quantity by Type (2018-2023) & (K Vials)
    Table 120. South America Liposomes Drug Delivery Sales Quantity by Type (2024-2029) & (K Vials)
    Table 121. South America Liposomes Drug Delivery Sales Quantity by Application (2018-2023) & (K Vials)
    Table 122. South America Liposomes Drug Delivery Sales Quantity by Application (2024-2029) & (K Vials)
    Table 123. South America Liposomes Drug Delivery Sales Quantity by Country (2018-2023) & (K Vials)
    Table 124. South America Liposomes Drug Delivery Sales Quantity by Country (2024-2029) & (K Vials)
    Table 125. South America Liposomes Drug Delivery Consumption Value by Country (2018-2023) & (USD Million)
    Table 126. South America Liposomes Drug Delivery Consumption Value by Country (2024-2029) & (USD Million)
    Table 127. Middle East & Africa Liposomes Drug Delivery Sales Quantity by Type (2018-2023) & (K Vials)
    Table 128. Middle East & Africa Liposomes Drug Delivery Sales Quantity by Type (2024-2029) & (K Vials)
    Table 129. Middle East & Africa Liposomes Drug Delivery Sales Quantity by Application (2018-2023) & (K Vials)
    Table 130. Middle East & Africa Liposomes Drug Delivery Sales Quantity by Application (2024-2029) & (K Vials)
    Table 131. Middle East & Africa Liposomes Drug Delivery Sales Quantity by Region (2018-2023) & (K Vials)
    Table 132. Middle East & Africa Liposomes Drug Delivery Sales Quantity by Region (2024-2029) & (K Vials)
    Table 133. Middle East & Africa Liposomes Drug Delivery Consumption Value by Region (2018-2023) & (USD Million)
    Table 134. Middle East & Africa Liposomes Drug Delivery Consumption Value by Region (2024-2029) & (USD Million)
    Table 135. Liposomes Drug Delivery Raw Material
    Table 136. Key Manufacturers of Liposomes Drug Delivery Raw Materials
    Table 137. Liposomes Drug Delivery Typical Distributors
    Table 138. Liposomes Drug Delivery Typical Customers
List of Figures
    Figure 1. Liposomes Drug Delivery Picture
    Figure 2. Global Liposomes Drug Delivery Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Liposomes Drug Delivery Consumption Value Market Share by Type in 2022
    Figure 4. Liposomal Doxorubicin Examples
    Figure 5. Liposomal Amphoteracin B Examples
    Figure 6. Liposomal Paclitaxel Examples
    Figure 7. Others Examples
    Figure 8. Global Liposomes Drug Delivery Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 9. Global Liposomes Drug Delivery Consumption Value Market Share by Application in 2022
    Figure 10. Fungal Infection Therapy Examples
    Figure 11. Cancer & Tumor Therapy Examples
    Figure 12. Others Examples
    Figure 13. Global Liposomes Drug Delivery Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Liposomes Drug Delivery Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Liposomes Drug Delivery Sales Quantity (2018-2029) & (K Vials)
    Figure 16. Global Liposomes Drug Delivery Average Price (2018-2029) & (USD/Vial)
    Figure 17. Global Liposomes Drug Delivery Sales Quantity Market Share by Manufacturer in 2022
    Figure 18. Global Liposomes Drug Delivery Consumption Value Market Share by Manufacturer in 2022
    Figure 19. Producer Shipments of Liposomes Drug Delivery by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 20. Top 3 Liposomes Drug Delivery Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Top 6 Liposomes Drug Delivery Manufacturer (Consumption Value) Market Share in 2022
    Figure 22. Global Liposomes Drug Delivery Sales Quantity Market Share by Region (2018-2029)
    Figure 23. Global Liposomes Drug Delivery Consumption Value Market Share by Region (2018-2029)
    Figure 24. North America Liposomes Drug Delivery Consumption Value (2018-2029) & (USD Million)
    Figure 25. Europe Liposomes Drug Delivery Consumption Value (2018-2029) & (USD Million)
    Figure 26. Asia-Pacific Liposomes Drug Delivery Consumption Value (2018-2029) & (USD Million)
    Figure 27. South America Liposomes Drug Delivery Consumption Value (2018-2029) & (USD Million)
    Figure 28. Middle East & Africa Liposomes Drug Delivery Consumption Value (2018-2029) & (USD Million)
    Figure 29. Global Liposomes Drug Delivery Sales Quantity Market Share by Type (2018-2029)
    Figure 30. Global Liposomes Drug Delivery Consumption Value Market Share by Type (2018-2029)
    Figure 31. Global Liposomes Drug Delivery Average Price by Type (2018-2029) & (USD/Vial)
    Figure 32. Global Liposomes Drug Delivery Sales Quantity Market Share by Application (2018-2029)
    Figure 33. Global Liposomes Drug Delivery Consumption Value Market Share by Application (2018-2029)
    Figure 34. Global Liposomes Drug Delivery Average Price by Application (2018-2029) & (USD/Vial)
    Figure 35. North America Liposomes Drug Delivery Sales Quantity Market Share by Type (2018-2029)
    Figure 36. North America Liposomes Drug Delivery Sales Quantity Market Share by Application (2018-2029)
    Figure 37. North America Liposomes Drug Delivery Sales Quantity Market Share by Country (2018-2029)
    Figure 38. North America Liposomes Drug Delivery Consumption Value Market Share by Country (2018-2029)
    Figure 39. United States Liposomes Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Canada Liposomes Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Mexico Liposomes Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 42. Europe Liposomes Drug Delivery Sales Quantity Market Share by Type (2018-2029)
    Figure 43. Europe Liposomes Drug Delivery Sales Quantity Market Share by Application (2018-2029)
    Figure 44. Europe Liposomes Drug Delivery Sales Quantity Market Share by Country (2018-2029)
    Figure 45. Europe Liposomes Drug Delivery Consumption Value Market Share by Country (2018-2029)
    Figure 46. Germany Liposomes Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. France Liposomes Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. United Kingdom Liposomes Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Russia Liposomes Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Italy Liposomes Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 51. Asia-Pacific Liposomes Drug Delivery Sales Quantity Market Share by Type (2018-2029)
    Figure 52. Asia-Pacific Liposomes Drug Delivery Sales Quantity Market Share by Application (2018-2029)
    Figure 53. Asia-Pacific Liposomes Drug Delivery Sales Quantity Market Share by Region (2018-2029)
    Figure 54. Asia-Pacific Liposomes Drug Delivery Consumption Value Market Share by Region (2018-2029)
    Figure 55. China Liposomes Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Japan Liposomes Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Korea Liposomes Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. India Liposomes Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Southeast Asia Liposomes Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. Australia Liposomes Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 61. South America Liposomes Drug Delivery Sales Quantity Market Share by Type (2018-2029)
    Figure 62. South America Liposomes Drug Delivery Sales Quantity Market Share by Application (2018-2029)
    Figure 63. South America Liposomes Drug Delivery Sales Quantity Market Share by Country (2018-2029)
    Figure 64. South America Liposomes Drug Delivery Consumption Value Market Share by Country (2018-2029)
    Figure 65. Brazil Liposomes Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Argentina Liposomes Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 67. Middle East & Africa Liposomes Drug Delivery Sales Quantity Market Share by Type (2018-2029)
    Figure 68. Middle East & Africa Liposomes Drug Delivery Sales Quantity Market Share by Application (2018-2029)
    Figure 69. Middle East & Africa Liposomes Drug Delivery Sales Quantity Market Share by Region (2018-2029)
    Figure 70. Middle East & Africa Liposomes Drug Delivery Consumption Value Market Share by Region (2018-2029)
    Figure 71. Turkey Liposomes Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Egypt Liposomes Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Saudi Arabia Liposomes Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. South Africa Liposomes Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 75. Liposomes Drug Delivery Market Drivers
    Figure 76. Liposomes Drug Delivery Market Restraints
    Figure 77. Liposomes Drug Delivery Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of Liposomes Drug Delivery in 2022
    Figure 80. Manufacturing Process Analysis of Liposomes Drug Delivery
    Figure 81. Liposomes Drug Delivery Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source